15 Lipoxygenase 1/ALOX15 Antibody (YA1309)
(Synonyms: LOG15)15 Lipoxygenase 1/ALOX15 Antibody (YA1309) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to 15 Lipoxygenase 1/ALOX15.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
IHC-P, ICC/IF, FC
-
Reactivity :
Human
-
Formulation:
Supplied in PBS, Glycerol and BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
|---|---|---|---|
| Dilution Ratio | 1:50-1:100 | 1:50 | 1:50-1:100 |
Product Details
15 Lipoxygenase 1/ALOX15 Antibody (YA1309) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to 15 Lipoxygenase 1/ALOX15.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman
-
Observed Molecular WeightObserved band size: 72 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 75 kDa
Peptide
Endogenous
Protein A
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS, Glycerol and BSA
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
15 Lipoxygenase 1/ALOX15 Atibody is a Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. It inserts peroxyl groups at C12 or C15 of arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) producing both 12-hydroperoxyeicosatetraenoate/12-HPETE and 15-hydroperoxyeicosatetraenoate/15-HPETE. It may then act on 12-HPETE to produce hepoxilins, which may show pro-inflammatory properties. Can also peroxidize linoleate ((9Z,12Z)-octadecadienoate) to 13-hydroperoxyoctadecadienoate/13-HPODE. May participate in the sequential oxidations of DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate specialized pro-resolving mediators (SPMs)like resolvin D5 ((7S,17S)-diHPDHA) and (7S,14S)-diHPDHA, that actively down-regulate the immune response and have anti-aggregation properties with platelets. Can convert epoxy fatty acids to hydroperoxy-epoxides derivatives followed by an intramolecular nucleophilic substitution leading to the formation of monocyclic endoperoxides. Plays an important role during the maintenance of self-tolerance by peroxidizing membrane-bound phosphatidylethanolamine which can then signal the sorting process for clearance of apoptotic cells during inflammation and prevent an autoimmune response. In addition to its role in the immune and inflammatory responses, this enzyme may play a role in epithelial wound healing in the cornea through production of lipoxin A4 (LXA(4)) and docosahexaenoic acid-derived neuroprotectin D1 (NPD1; 10R,17S-HDHA), both lipid autacoids exhibit anti-inflammatory and neuroprotective properties. Furthermore, it may regulate actin polymerization which is crucial for several biological processes such as the phagocytosis of apoptotic cells. It is also implicated in the generation of endogenous ligands for peroxisome proliferator activated receptor (PPAR-gamma), hence modulating macrophage development and function. It may also exert a negative effect on skeletal development by regulating bone mass through this pathway. As well as participates in ER stress and downstream inflammation in adipocytes, pancreatic islets, and liver. Finally, it is also involved in the cellular response to IL13/interleukin-13[1][2][3][4][5][6][7].
-
Subcellular Localization
Cytoplasm, cytosol; Cell membrane; Peripheral membrane protein; Lipid droplet
-
Expression
Tissue_specificity:Detected in monocytes and eosinophils (protein levels) . Expressed in airway epithelial cells.
Induction:Up-regulated by UV-irradiation -
Isoforms & Post-Translational Modification
P16050 has 2 isomers: P16050-1: 74804 Da (predicted); P16050-2: 70108 Da (predicted).
-
Subunit
Interacts with PEBP1; in response to IL13/interleukin-13, prevents the interaction of PEBP1 with RAF1 to activate the ERK signaling cascade
-
SwissProt ID
-
Synonyms
LOG15
-
Research Field
Tumor biology
Documentation
References
[1]. Andersson E, et al. Interaction of human 15-lipoxygenase-1 with phosphatidylinositol bisphosphates results in increased enzyme activity. Biochim Biophys Acta. 2006 Dec;1761(12):1498-505. [Content Brief]
[2]. Sloane DL, et al. A primary determinant for lipoxygenase positional specificity. Nature. 1991 Nov 14;354(6349):149-52. [Content Brief]
[3]. Horn T, et al. Functional characterization of genetic enzyme variations in human lipoxygenases. Redox Biol. 2013;1(1):566-77. [Content Brief]
[4]. Teder T, et al. Lipoxygenase-catalyzed transformation of epoxy fatty acids to hydroxy-endoperoxides: a potential P450 and lipoxygenase interaction. J Lipid Res. 2014 Dec;55(12):2587-96. [Content Brief]
[5]. Perry SC, et al. 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5. J Lipid Res. 2020 Jul;61(7):1087-1103. [Content Brief]
[6]. Kühn H, et al. Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim Biophys Acta. 1993 Jul 21;1169(1):80-9. [Content Brief]
[7]. Zhao J, et al. 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells. Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14246-51. [Content Brief]